More on the pathogenesis of thrombotic thrombocytopenic purpura. Comment on "Acquired thrombotic thrombocytopenic purpura without detectable anti-ADAMTS13 antibodies: a possible underlying autoimmune mechanism" and on "The different faces of thrombotic thrombocytopenic purpura". [PDF]
Peyvandi F.
europepmc +1 more source
Caplacizumab therapy for relapsed immune thrombotic thrombocytopenic purpura
Agata Ogłoza, Andrzej Mital
openalex +2 more sources
Experience in emergency management of first-episode immune thrombotic thrombocytopenic purpura over the past 21 years: a single-center retrospective study. [PDF]
Zhang L +7 more
europepmc +1 more source
Novel mechanisms of action of emerging therapies of hereditary thrombotic thrombocytopenic purpura [PDF]
X. Long Zheng
openalex +1 more source
Thrombotic thrombocytopenic purpura in pregnancy: A case report and literature review. [PDF]
Andreatidis B +5 more
europepmc +1 more source
Diagnostik und Therapie der Immunthrombozytopenie [PDF]
Giagounidis, Aristoteles +9 more
core +1 more source
Prognostic value of laboratory biomarkers for mortality risk stratification in thrombotic thrombocytopenic purpura. [PDF]
Xiang X, Dai YQ.
europepmc +1 more source
A Clever Stroke Mimic: Thrombotic Thrombocytopenic Purpura Without Schistocytes - A Case Report and Literature Review. [PDF]
Takamatsu K +4 more
europepmc +1 more source

